Iniciar sesión

Pierangelo Barbero

Clinical and Biological Sciences Department,
Neurology Unit,
Clinical and Biological Sciences Department, Neurology Unit

University of Torino, San Luigi Gonzaga Hospital

BIOGRAPHY

Pierangelo Barbero has not added Biography.

If you are Pierangelo Barbero and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

Lancet (London, England) Apr, 2002 | Pubmed ID: 11988242

Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.

Journal of neurology Jun, 2002 | Pubmed ID: 12111305

Re: Vartanian T. An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis. Clin Ther. 2003;25:105-118.

Clinical therapeutics Jun, 2003 | Pubmed ID: 12868445

High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study.

Journal of the neurological sciences Jul, 2004 | Pubmed ID: 15240190

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.

Neurology Dec, 2006 | Pubmed ID: 17190964

Adherence to interferon-beta treatment and results of therapy switching.

Journal of the neurological sciences Aug, 2007 | Pubmed ID: 17376486

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.

Journal of neurology Sep, 2008 | Pubmed ID: 18825438

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.

Journal of neuroimmunology Sep, 2010 | Pubmed ID: 20573405

Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.

Journal of neurology Dec, 2015 | Pubmed ID: 26410746

INSTITUTIONS

University of Torino, San Luigi Gonzaga Hospital

JOVE ARTICLES

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Pierangelo Barbero¹,

Marco Busso²,

Carlo Alberto Artusi¹,

Stefania De Mercanti¹,

Marco Tinivella³,

Andrea Veltri²,

Luca Durelli¹,

Marinella Clerico¹

¹Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital,

²Oncology Department, Radiology Unit, University of Torino, San Luigi Gonzaga Hospital,

³Clinical and Biological Sciences Department, Dietologic and Nutrition Unit, University of Torino, San Luigi Gonzaga Hospital

Medicine

Privacidad

Condiciones de uso

Políticas

Contáctenos

RECOMIENDE A LA BIBLIOTECA

BOLETINES de JoVE

Investigación

JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo

Educación

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Faculty Site

Autores

Descripción
Proceso de publicación
Comité editorial
Ámbito y políticas
Revisión por pares
Preguntas frecuentes
Enviar

Bibliotecarios

Descripción
Testimonios
Suscripciones
Acceso
Recursos
Junta Asesora de Bibliotecarios
Preguntas frecuentes

ACERCA DE JoVE

Descripción
Liderazgo
Blog
JoVE Help Center
JoVE Sitemap

Pierangelo Barbero

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Clinical and Biological Sciences Department,Neurology Unit,Clinical and Biological Sciences Department, Neurology Unit

University of Torino, San Luigi Gonzaga Hospital

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Clinical and Biological Sciences Department,
Neurology Unit,
Clinical and Biological Sciences Department, Neurology Unit